-
Development and Implementation of a Dynamic Framework for Assessment and Improvement of Registries’ Data Quality
Sep 9, 2025, 16:22 PM -
What Is the Cost of Preventing Tuberculosis a Cost-Effectiveness Analysis of Household Contact Tracing With 3HP Preventive Therapy in High-Burden Areas of Nepal?
Sep 9, 2025, 16:22 PM -
Development of the Adelphi Caregiver Experience Questionnaire© (ACARE): A Novel Tool Designed to Measure and Understand the Burden and Quality of Life Impacts of the Caregiver Role
Sep 9, 2025, 16:22 PM -
From the Outside Looking in: Patient Advocacy Groups' and Healthcare Providers' Perspectives on Patient Engagement Strategies in the Israeli Health Technology Assessment Process
Sep 9, 2025, 16:22 PM -
Leveraging AI for Evidence Synthesis: Assessing the Accuracy and Efficiency of AI-Supported Data Extraction and Reporting
Sep 9, 2025, 16:22 PM -
Let LAMBA Do the Work: Can We Reduce Reliance on VBA in Health Economic Models?
Sep 9, 2025, 16:22 PM -
Rising EAP Rejection Rates and Their Impact on Drug Access in France
Sep 9, 2025, 16:22 PM -
A Cost-Utility Analysis of Ferric Derisomaltose vs. Ferric Carboxymaltose in Patients with Iron Deficiency Anemia and Inflammatory Bowel Disease in the United Kingdom: Accounting for Difference in Fracture Risk
Sep 9, 2025, 16:22 PM -
Assessing the Cost-Effectiveness of Lecanemab for Early Alzheimer's Disease Treatment: A Swiss Perspective
Sep 9, 2025, 16:22 PM -
Bridging the Gap: How Early Access Shapes Pricing and Reimbursed Populations in France
Sep 9, 2025, 16:22 PM -
Predicting Outcomes and Estimating Minimum Sample Sizes for Divozilimab Efficacy in NMOSD: A Clinical Trial Simulation and Unanchored Matching-Adjusted Indirect Comparison
Sep 9, 2025, 16:22 PM -
Comparing Individualized Treatment Effect Inference Methods Through a Simulation Study
Sep 9, 2025, 16:22 PM -
When Cost-Effectiveness No Longer Counts: Industry Views on the Undermining of HTA Principles in Korea
Sep 9, 2025, 16:22 PM -
Methodological Challenges for the Economic Evaluation of Genomic Newborn Screening: A Scoping Review
Sep 9, 2025, 16:22 PM -
Economic Burden of Type 1 Diabetes Mellitus After Disease Onset: A Claims Data Analysis
Sep 9, 2025, 16:22 PM -
Regulatory Timelines for CMA Medicines In Italy: A Comparative Analysis of Pricing and Reimbursement Procedures
Sep 9, 2025, 16:22 PM -
Impact of Transfusion-Dependent Thalassemia on Adult Patients’ Health-Related Quality of Life and Work Productivity in the Kingdom of Saudi Arabia and United Arab Emirates
Sep 9, 2025, 16:22 PM -
Establishing the Relationship Between the Worst Itch Numerical Rating Scale and EQ-5D Utility in Patients With Primary Biliary Cholangitis Experiencing Pruritus: Pooled Results From GLIMMER and the PRO Validation Study
Sep 9, 2025, 16:22 PM -
The Impact of Early Antibacterial Therapy on ICU Patient Outcomes for Sepsis: A Causal Analysis
Sep 9, 2025, 16:22 PM -
Real-World Hospital Stays Description and Cost Analysis of Immune Checkpoint Inhibitors (ICIs) Using National PMSI Data in France
Sep 9, 2025, 16:22 PM
